Holoprosencephaly and Recurrent Episodes of Severe Neurogenic Hypernatremia

Abstract

Holoprosencephaly (HPE) is a severe and complex malformation caused by incomplete cleavage of the prosencephalon and incomplete development of paramedian structures. Many causes have been recognized as responsible for this malformation including maternal diabetes, chromosomal abnormalities, and heterozygous mutations, involving four major genes (SHH, Z1C2, SIX3, and TGIF) and other less frequently reported genes. HPE has frequently been reported as a feature of complex malformative syndromes such as Smith–Lemli–Opitz syndrome, CHARGE syndrome (acronym of Coloboma, Heart defects, choanal Atresia, Retardation of growth and/or development, Genitourinary malformation and Ear abnormalities), and Rubinstein–Taybi syndrome. Moreover, children with HPE may present with other anomalies aside from those of the brain and face, including endocrine disorders such as diabetes insipidus, adrenal hypoplasia, hypogonadism, thyroid hypoplasia, and growth hormone deficiency. We report a boy with typical clinical signs of HPE including neuroradiologic findings resembling severe congenital hydrocephalus. The patient also presented with a specific metabolic anomaly consisting of recurrent episodes of hypernatremia.

Keywords

holoprosencephaly - congenital hydrocephalus - neurogenic hypernatremia - pediatrics

• References

• 1 Mercier S, Dubourg C, Garcelon N , et al. New findings for phenotype-genotype correlations in a large European series of holoprosencephaly cases. J Med Genet 2011; 48 (11) 752-760
• 2 Johnson CY, Rasmussen SA. Non-genetic risk factors for holoprosencephaly. Am J Med Genet C Semin Med Genet 2010; 154C (1) 73-85
• 3 Kauvar EF, Muenke M. Holoprosencephaly: recommendations for diagnosis and management. Curr Opin Pediatr 2010; 22 (6) 687-695
• 4 Mercier S, Dubourg C, Belleguic M , et al. Genetic counseling and “molecular” prenatal diagnosis of holoprosencephaly (HPE). Am J Med Genet C Semin Med Genet 2010; 154C (1) 191-196
• 5 Yamasaki M, Nonaka M, Bamba Y, Teramoto C, Ban C, Pooh RK. Diagnosis, treatment, and long-term outcomes of fetal hydrocephalus. Semin Fetal Neonatal Med 2012; 17 (6) 330-335
• 6 Yoneda Y, Haginoya K, Kato M , et al. Phenotypic spectrum of COL4A1 mutations: porencephaly to schizencephaly. Ann Neurol 2013; 73 (1) 48-57
• 7 Ramesh VG. Hydranencephaly vs hydrocephalus. Neurosurgery 2010; 67 (5) E1472
• 8 Hsu P, Ma A, Wilson M , et al. CHARGE syndrome: a review. J Paediatr Child Health 2014; 50 (7) 504-511
• 9 Nowaczyk MJ, Irons MB. Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology. Am J Med Genet C Semin Med Genet 2012; 160C (4) 250-262
• 10 Parsley L, Bellus G, Handler M, Tsai AC. Identical twin sisters with Rubinstein-Taybi syndrome associated with Chiari malformations and syrinx. Am J Med Genet A 2011; 155A (11) 2766-2770
• 11 Lazaro L, Dubourg C, Pasquier L , et al. Phenotypic and molecular variability of the holoprosencephalic spectrum. Am J Med Genet A 2004; 129A (1) 21-24
• 12 Savasta S, Chiapedi S, Borali E , et al. Holoprosencephaly with neurogenic hypernatremia: a new case. Childs Nerv Syst 2008; 24 (1) 139-142
• 13 Devuyst O. Physiopathology and diagnosis of nephrogenic diabetes insipidus. Ann Endocrinol (Paris) 2012; 73 (2) 128-129
• 14 Cuisset JM, Cuvellier JC, Vallée L, Ryckewäert P, Soto-Ares G, Nuyts JP. Holoprosencephaly with neurogenic hypernatremia [in French]. Arch Pediatr 1999; 6 (1) 43-45
• 15 Solomon BD, Gropman A, Muenke M. Holoprosencephaly overview. In: Pagon RA, Adam MP, Ardinger HH, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington; 1993–2014 [updated August 29, 2013]